Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

about

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy

P2860

Q57491231-1AD9949E-7A6B-4000-8838-A1D0CE3A016E

P2860

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

Item

http://www.wikidata.org/entity/Q47775953

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@en

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@nl

type

Item

label

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@en

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@nl

prefLabel

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@en

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@nl

P1476

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

@en

P2093

Chigusa Morizane

http://www.w3.org/2001/XMLSchema#string

Hiroshi Ishii

http://www.w3.org/2001/XMLSchema#string

Junji Furuse

http://www.w3.org/2001/XMLSchema#string

Makoto Ueno

http://www.w3.org/2001/XMLSchema#string

Masafumi Ikeda

http://www.w3.org/2001/XMLSchema#string

Takuji Okusaka

http://www.w3.org/2001/XMLSchema#string

P2860

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

Management of hepatocellular carcinoma: An update

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Sorafenib in advanced hepatocellular carcinoma

Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

P31

scholarly article

review article

P356

10.1093/JJCO/HYX180

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29253194

http://www.w3.org/2001/XMLSchema#string

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

about

P2860

P2860

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P577

P698